P8574

Sodium pyruvate

BioXtra, ≥99%

• Synonym(s): α-Ketopropionic acid sodium salt, 2-Oxopropanoic acid sodium salt, Pyruvic acid sodium salt
• Linear Formula: CH₃COCOONa
• CAS Number: 113-24-6
• Molecular Weight: 110.04
• Beilstein: 3568341
• EC Number: 204-024-4
• MDL number: MFCD00002586
• UNSPSC Code: 12352207
• PubChem Substance ID: 24898951
• NACRES: NA.71

Properties

• product line: BioXtra
• Quality Level: 200
• Assay: ≥99%
• form: powder
• impurities: ≤0.005% Phosphorus (P); ≤0.1% Insoluble matter
• mp: >300 °C (lit.)
• solubility: H₂O: 1 M, clear, colorless
• anion traces: chloride (Cl^-): ≤0.05%; sulfate (SO₄^2-): ≤0.05%
• cation traces: Al: ≤0.0005%; Ca: ≤0.001%; Cu: ≤0.0005%; Fe: ≤0.0005%; K: ≤0.005%; Mg: ≤0.0005%; NH₄⁺: ≤0.05%; Pb: ≤0.001%; Zn: ≤0.0005%
• storage temp.: 2-8°C
• SMILES string: [Na+].CC(=O)C([O-])=O
• InChI: 1S/C3H4O3.Na/c1-2(4)3(5)6;/h1H3,(H,5,6);/q;+1/p-1
• InChI key: DAEPDZWVDSPTHF-UHFFFAOYSA-M

Description

Application

Sodium pyruvate has been used as a component:

• of cutting solution for rat brain tissue slice preparation
• of M-199 medium for the maturation of oocytes
• of Krebs-Henseleit buffer for plasma incubation

Biochem/physiol Actions

Sodium pyruvate based therapeutic regimen is effective for treating mitochondrial diseases. It decreases tissue damage associated with the pathophysiology of brain damage, haemorrhagic shock and ischemia-reperfusion injury models.

Safety Information

• Pictograms: GHS07
• Signal Word: Warning
• Hazard Statements: H317 - H319
• Precautionary Statements: P280 - P302 + P352 - P305 + P351 + P338
• Hazard Classifications: Eye Irrit. 2 - Skin Sens. 1B
• Storage Class Code: 13 - Non Combustible Solids
• WGK: WGK 1
• Flash Point(F): Not applicable
• Flash Point(C): Not applicable
• Personal Protective Equipment: dust mask type N95 (US), Eyeshields, Gloves